GEP20135986B - Novel sustained release composition of compounds selected from class of centrally acting muscle relaxants - Google Patents

Novel sustained release composition of compounds selected from class of centrally acting muscle relaxants

Info

Publication number
GEP20135986B
GEP20135986B GEAP201012409A GEAP2010012409A GEP20135986B GE P20135986 B GEP20135986 B GE P20135986B GE AP201012409 A GEAP201012409 A GE AP201012409A GE AP2010012409 A GEAP2010012409 A GE AP2010012409A GE P20135986 B GEP20135986 B GE P20135986B
Authority
GE
Georgia
Prior art keywords
class
sustained release
compounds selected
release composition
muscle relaxants
Prior art date
Application number
GEAP201012409A
Inventor
Shashikant Prabhudas Kurani
Sachin Dinesh Patel
Dinesh Shantilal Patel
Original Assignee
Shashikant Prabhudas Kurani
Sachin Dinesh Patel
Dinesh Shantilal Patel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shashikant Prabhudas Kurani, Sachin Dinesh Patel, Dinesh Shantilal Patel filed Critical Shashikant Prabhudas Kurani
Publication of GEP20135986B publication Critical patent/GEP20135986B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

There is represented composition containing Tol¬perisone and/or Eperisone combined with other pharmaceutical substances, pharmaceutically accep¬table fillers and at least an agent releasing sustained active ingredient; at that, Tolperisone and/or Eperi¬sone mass correlation with agent releasing active ingredient varies from 1:0.5 to 1:3.
GEAP201012409A 2009-03-09 2010-03-09 Novel sustained release composition of compounds selected from class of centrally acting muscle relaxants GEP20135986B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN522MU2009 2009-03-09

Publications (1)

Publication Number Publication Date
GEP20135986B true GEP20135986B (en) 2013-12-10

Family

ID=42728892

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP201012409A GEP20135986B (en) 2009-03-09 2010-03-09 Novel sustained release composition of compounds selected from class of centrally acting muscle relaxants

Country Status (5)

Country Link
EP (1) EP2405900A2 (en)
CN (1) CN102438597A (en)
EA (1) EA201171109A1 (en)
GE (1) GEP20135986B (en)
WO (1) WO2010103544A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2013000001A (en) 2010-07-06 2013-05-01 Navipharm Co Ltd Time-delayed sustained release pharmaceutical composition comprising dapoxetine for oral administration.
WO2012172413A1 (en) 2011-06-16 2012-12-20 Abbott Healthcare Pvt. Ltd. Pharmaceutical composition comprising a combination of eperisone and diclofenac and process for preparing thereof
KR101156054B1 (en) * 2011-09-05 2012-06-20 주식회사 네비팜 A stable and control-released pharmaceutical composition comprising eperisone
KR101832842B1 (en) * 2012-01-13 2018-02-27 한미약품 주식회사 Pharmaceutical composition with an improved stability comprising eperisone or a pharmaceutically acceptable salt thereof and specific acidifying agent
WO2013149258A2 (en) 2012-03-30 2013-10-03 Charles Drew University of Medicine and Science Compositions and methods for treating or preventing metabolic syndrome disorders
CN102895206A (en) * 2012-10-31 2013-01-30 中国药科大学 Rhizoma bletillae polysaccharide gastric-floating tablet and preparation method and application thereof
US20140271923A1 (en) 2013-03-14 2014-09-18 Christopher Brian Reid Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
KR101497354B1 (en) * 2013-03-29 2015-03-02 초당약품공업 주식회사 Slow release pharmaceutical composition having Eperisone as active ingredient
CN103432093B (en) * 2013-08-31 2015-03-25 西南大学 Pridinol methanesulfonate matrix sustained-release tablet and preparation method thereof
ES2582878T3 (en) * 2013-09-12 2016-09-15 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical formulation comprising a combination of a muscle relaxant and an analgesic
PL2848260T3 (en) * 2013-09-12 2016-09-30 Novel formulations of thiocolchicoside
PL2848259T3 (en) * 2013-09-12 2016-09-30 Sustained release pharmaceutical formulations of Thiocolchicoside
CN104688709A (en) * 2015-03-24 2015-06-10 北京世桥生物制药有限公司 Fumaric acid quetiapine composition sustained-release tablet and preparing method thereof
WO2018044020A1 (en) * 2016-08-29 2018-03-08 초당약품공업 주식회사 Method for preparing eperisone sustained release microsphere, and composite preparation of eperisone sustained release microsphere and aceclofenac
TR201720293A2 (en) 2017-12-13 2019-06-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Tolperisone and non-selective cox inhibitor combinations
TR201720289A2 (en) * 2017-12-13 2019-06-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Tolperizon and Selective COX-2 Inhibitor Combinations
TR201819202A2 (en) * 2018-12-12 2020-06-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi A COMBINATION CONTAINING ONE MULTIPLE SCLEROSIS AGENT AND AT LEAST ONE MUSCLE RELAXING AGENT
TR201906487A1 (en) 2019-04-30 2020-11-23 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi PHARMACEUTICAL COMPOSITIONS CONTAINING TOLPERISONE AND NIMESULIDE COMBINATIONS

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0720866B2 (en) * 1987-05-15 1995-03-08 三生製薬株式会社 Transdermal preparation containing eperisone or tolperisone or their salts
JPS6485915A (en) 1987-09-28 1989-03-30 Eisai Co Ltd Hypotensor
US5252588A (en) * 1990-04-27 1993-10-12 Sekisui Kagaku Kogyo Kabushiki Kaisha Percutaneously absorbable crosslinked polyvinylpyrrolidone eperisone or tolperisone preparation
CA2107678A1 (en) 1991-04-08 1992-10-09 Kouichi Nakamichi Capsule
AT409083B (en) 1999-04-01 2002-05-27 Sanochemia Pharmazeutika Ag PHARMACEUTICAL PREPARATION CONTAINING TOLPERISON FOR ORAL ADMINISTRATION
US6753011B2 (en) 2000-01-14 2004-06-22 Osmotica Corp Combined diffusion/osmotic pumping drug delivery system
KR100433614B1 (en) * 2000-06-16 2004-05-31 주식회사 태평양 Transdermal Preparation Containing Hydrophilic or Salt-form Drug
US6733781B2 (en) 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
US20040224012A1 (en) 2001-10-05 2004-11-11 Pichit Suvanprakorn Topical application and methods for administration of active agents using liposome macro-beads
KR100511492B1 (en) * 2002-10-11 2005-08-31 주식회사 태평양 Transdermal preparations comprising eperisone, tolperisone or salts thereof
AT500144A1 (en) * 2004-03-05 2005-11-15 Sanochemia Pharmazeutika Ag TOLPERISON-CONTAINING PHARMACEUTICAL PREPARATION WITH CONTROLLABLE ACTIVE INGREDIENTS FOR ORAL ADMINISTRATION
US20060004050A1 (en) 2004-07-02 2006-01-05 Speicher Brian T Compositions and methods for the prevention or treatment of pain and other nervous system disorders
CN101002752A (en) * 2005-09-26 2007-07-25 刘凤鸣 Slow release preparation of tropyone
MX2008013437A (en) 2006-04-20 2009-03-06 Sanochemia Pharmazeutika Ag Method for administering tolperisone.
HUP0700485A3 (en) * 2007-07-23 2010-01-28 Richter Gedeon Nyrt Pharmaceutical composition with controlled release containing tolperisone

Also Published As

Publication number Publication date
WO2010103544A4 (en) 2011-06-03
WO2010103544A2 (en) 2010-09-16
EA201171109A1 (en) 2012-03-30
EP2405900A2 (en) 2012-01-18
WO2010103544A3 (en) 2011-04-07
CN102438597A (en) 2012-05-02

Similar Documents

Publication Publication Date Title
GEP20135986B (en) Novel sustained release composition of compounds selected from class of centrally acting muscle relaxants
EA201071054A1 (en) HARD DRUGS DISSOLVING IN THE MOUTH
MX2010007609A (en) Capsule formulation.
MX2010014234A (en) Pyrazole compounds 436.
EA200700049A1 (en) PREPARATIVE FORMS OF ORAL MEDICINAL FORMS OF MEMANTINE WITH MODIFIED SURVIVAL
EA200901319A1 (en) COMPOSITIONS FOR BOTTOM INTRODUCTION
NZ594022A (en) Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof
GEP20146102B (en) Compounds and compositions as protein kinase inhibitors
AR068369A1 (en) N4 XINAFOATE SALT - [(2,2-DIFLUOR-4H-BENZO [1,4] OXAZIN-3-ON) -6-IL] -5-FLUOR-N2- [3- (METHYLAMINOCARBONYLMETHYLENE) -FENYL] 2 , 4-PYRIMIDINDIAMINE "
RU2015124694A (en) SELF-ADJUSTABLE RELEASE OF PHARMACEUTICAL INGREDIENT
EA201291372A1 (en) PHARMACEUTICAL COMPOSITION, CONTAINING DROSPYRENON, AND SET FOR PREVENTION OF CONCUSSION
WO2008132710A3 (en) Pharmaceutical nimodipine compositions
HRP20110745T1 (en) Delayed release rasagiline formulation
WO2009063222A3 (en) Solid compositions
EA201071218A1 (en) IMPROVED COMPOSITIONS FOR ACTIVE PHARMACEUTICAL COMPONENTS WITH BAD PERMEABILITY
WO2009091576A3 (en) Parenteral formulations of dopamine agonists
RU2014101227A (en) COATING COMPOSITION SUITABLE FOR PHARMACEUTICAL OR NUTRICEUTIC MEDICINAL FORMS
WO2011112922A3 (en) Co-crystals and pharmaceutical formulations comprising the same
DK1843754T3 (en) New pharmaceutical composition containing candesartan cilexetil as lipophilic crystalline substance
NZ589017A (en) Solid pharmaceutical formulation with delayed release
EA201101596A1 (en) COMPOSITION FOR CONTINUOUS DELIVERY OF MEDICINE CONTAINING CONTAINING GEOPOLYMERIC CONNECTING
WO2009060952A1 (en) Novel preparation
MX2012007365A (en) Slow release pharmaceutical compositions of iloperidone.
NZ597317A (en) Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
EP2345326A3 (en) Fly attractant composition containing a ligninsulfonate as active agent